JP2010521437A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521437A5 JP2010521437A5 JP2009553136A JP2009553136A JP2010521437A5 JP 2010521437 A5 JP2010521437 A5 JP 2010521437A5 JP 2009553136 A JP2009553136 A JP 2009553136A JP 2009553136 A JP2009553136 A JP 2009553136A JP 2010521437 A5 JP2010521437 A5 JP 2010521437A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- starch
- preparation according
- weight
- sealing layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000825 pharmaceutical preparation Substances 0.000 claims 15
- 239000011248 coating agent Substances 0.000 claims 11
- 238000000576 coating method Methods 0.000 claims 11
- 238000007789 sealing Methods 0.000 claims 11
- 229920000642 polymer Polymers 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 229920002472 Starch Polymers 0.000 claims 7
- 235000019698 starch Nutrition 0.000 claims 7
- 239000008107 starch Substances 0.000 claims 7
- 239000002202 Polyethylene glycol Substances 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 6
- 229920013820 alkyl cellulose Polymers 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 6
- 229940032147 starch Drugs 0.000 claims 6
- 229920002678 cellulose Polymers 0.000 claims 4
- 239000001913 cellulose Substances 0.000 claims 4
- 235000010980 cellulose Nutrition 0.000 claims 4
- 239000007884 disintegrant Substances 0.000 claims 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 4
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 3
- 229920000881 Modified starch Polymers 0.000 claims 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 3
- 229920001477 hydrophilic polymer Polymers 0.000 claims 3
- 235000019426 modified starch Nutrition 0.000 claims 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 2
- TYVWBCMQECJNSK-UHFFFAOYSA-N [2-methyl-3-(2-methylprop-2-enoyloxy)butan-2-yl]azanium;chloride Chemical compound [Cl-].CC([NH3+])(C)C(C)OC(=O)C(C)=C TYVWBCMQECJNSK-UHFFFAOYSA-N 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 2
- 229920000609 methyl cellulose Polymers 0.000 claims 2
- 239000001923 methylcellulose Substances 0.000 claims 2
- 235000010981 methylcellulose Nutrition 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- APXRHPDHORGIEB-UHFFFAOYSA-N 1H-pyrazolo[4,3-d]pyrimidine Chemical class N1=CN=C2C=NNC2=C1 APXRHPDHORGIEB-UHFFFAOYSA-N 0.000 claims 1
- 229920000856 Amylose Polymers 0.000 claims 1
- 229920002261 Corn starch Polymers 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 239000004368 Modified starch Substances 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical group C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229940125681 anticonvulsant agent Drugs 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 239000002249 anxiolytic agent Substances 0.000 claims 1
- 230000000949 anxiolytic effect Effects 0.000 claims 1
- 229940005530 anxiolytics Drugs 0.000 claims 1
- 229940049706 benzodiazepine Drugs 0.000 claims 1
- 125000003310 benzodiazepinyl group Chemical group N1N=C(C=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 229920002301 cellulose acetate Polymers 0.000 claims 1
- 229920001531 copovidone Polymers 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 239000003326 hypnotic agent Substances 0.000 claims 1
- 230000000147 hypnotic effect Effects 0.000 claims 1
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 claims 1
- 229940035363 muscle relaxants Drugs 0.000 claims 1
- 239000003158 myorelaxant agent Substances 0.000 claims 1
- 150000002990 phenothiazines Chemical class 0.000 claims 1
- 229920002689 polyvinyl acetate Polymers 0.000 claims 1
- 239000011118 polyvinyl acetate Substances 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 229920001592 potato starch Polymers 0.000 claims 1
- 229940125723 sedative agent Drugs 0.000 claims 1
- 239000000932 sedative agent Substances 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 1
- 229920003109 sodium starch glycolate Polymers 0.000 claims 1
- 239000008109 sodium starch glycolate Substances 0.000 claims 1
- 229940079832 sodium starch glycolate Drugs 0.000 claims 1
- 229940071117 starch glycolate Drugs 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 229960004010 zaleplon Drugs 0.000 claims 1
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical group CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07104213A EP1970056A1 (en) | 2007-03-15 | 2007-03-15 | Time-specific delayed/pulsatile release dosage forms |
| PCT/EP2008/052957 WO2008110577A1 (en) | 2007-03-15 | 2008-03-12 | Time- specific delayed/pulsatile release dosage forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010521437A JP2010521437A (ja) | 2010-06-24 |
| JP2010521437A5 true JP2010521437A5 (OSRAM) | 2010-12-16 |
Family
ID=38063792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553136A Pending JP2010521437A (ja) | 2007-03-15 | 2008-03-12 | 時間特異的遅延／パルス放出剤形 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100028426A1 (OSRAM) |
| EP (2) | EP1970056A1 (OSRAM) |
| JP (1) | JP2010521437A (OSRAM) |
| KR (1) | KR20090119986A (OSRAM) |
| CN (1) | CN101636153A (OSRAM) |
| AR (1) | AR065778A1 (OSRAM) |
| BR (1) | BRPI0808801A2 (OSRAM) |
| CA (1) | CA2679210A1 (OSRAM) |
| MX (1) | MX2009009862A (OSRAM) |
| RU (1) | RU2452472C2 (OSRAM) |
| WO (1) | WO2008110577A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101601649B1 (ko) | 2008-04-18 | 2016-03-09 | 인텍 파마 리미티드 | 카르비도파／레보도파 위체류 약물 전달 |
| EP2378883B1 (en) * | 2008-12-04 | 2015-12-23 | Intec Pharma Ltd. | Zaleplon gastroretentive drug delivery system |
| US20120039954A1 (en) * | 2008-12-15 | 2012-02-16 | Somnus Therapeutics, Inc. | Method of treating insomnia |
| CN103816130B (zh) * | 2014-01-22 | 2016-01-20 | 悦康药业集团有限公司 | 一种盐酸二甲双胍缓释片 |
| JP7227896B2 (ja) * | 2016-07-11 | 2023-02-22 | コンテラ ファーマ エー／エス | 朝の無動状態を治療するための拍動性薬物送達系 |
| IT202000011050A1 (it) * | 2020-05-14 | 2021-11-14 | Mogon Pharmaceuticals Sagl | Composizioni orali solide comprendenti matrici monolitiche composite per la somministrazione cronotropica nel tratto gastroenterico di ingredienti attivi |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4309404A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
| EP0546593B1 (en) * | 1991-10-30 | 1997-09-03 | Glaxo Group Limited | Multi-layered compositions containing histamine or serotonin antagonists |
| WO1993019741A1 (en) * | 1992-03-31 | 1993-10-14 | Benzon Pharma A/S | A pharmaceutical formulation |
| GB9619074D0 (en) * | 1996-09-12 | 1996-10-23 | Smithkline Beecham Plc | Composition |
| US5788987A (en) * | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
| US5891474A (en) * | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
| CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
| SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
| EP1064937A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| DK1206248T3 (da) * | 1999-08-26 | 2003-09-29 | Neurocrine Biosciences Inc | Sedativ-hypnotiske præparater med kontrolleret frigivelse og fremgangsmåder relaterede dertil |
| WO2001080824A2 (en) * | 2000-04-19 | 2001-11-01 | Eurand America, Inc. | Dual mechanism timed release dosage forms for low dose drugs |
| US6811794B2 (en) * | 2001-12-20 | 2004-11-02 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| US20060257482A1 (en) * | 2002-06-07 | 2006-11-16 | Patrik Kumar | Modified release, multiple unit drug delivery systems |
| US20050038042A1 (en) * | 2002-11-15 | 2005-02-17 | Jenet Codd | Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| US20050158383A1 (en) * | 2003-10-21 | 2005-07-21 | Garth Boehm | Quetiapine formulations |
| AR052225A1 (es) * | 2004-11-04 | 2007-03-07 | Astrazeneca Ab | Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones |
| AU2005305459A1 (en) * | 2004-11-22 | 2006-05-26 | Dexcel Pharma Technologies Ltd. | Controlled absorption of statins in the intestine |
| EP1863449A2 (en) * | 2005-03-28 | 2007-12-12 | Dexcel Pharma Technologies Ltd. | Controlled absorption of statins in the intestine |
| CA2600282A1 (en) * | 2005-03-29 | 2006-10-05 | Roehm Gmbh | Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
| US20060280795A1 (en) * | 2005-06-08 | 2006-12-14 | Dexcel Pharma Technologies, Ltd. | Specific time-delayed burst profile delivery system |
-
2007
- 2007-03-15 EP EP07104213A patent/EP1970056A1/en not_active Withdrawn
-
2008
- 2008-03-12 US US12/450,201 patent/US20100028426A1/en not_active Abandoned
- 2008-03-12 JP JP2009553136A patent/JP2010521437A/ja active Pending
- 2008-03-12 MX MX2009009862A patent/MX2009009862A/es not_active Application Discontinuation
- 2008-03-12 CN CN200880008426A patent/CN101636153A/zh active Pending
- 2008-03-12 KR KR1020097020728A patent/KR20090119986A/ko not_active Ceased
- 2008-03-12 RU RU2009138048/15A patent/RU2452472C2/ru not_active IP Right Cessation
- 2008-03-12 EP EP08717703A patent/EP2120888A1/en not_active Withdrawn
- 2008-03-12 WO PCT/EP2008/052957 patent/WO2008110577A1/en not_active Ceased
- 2008-03-12 CA CA002679210A patent/CA2679210A1/en not_active Abandoned
- 2008-03-12 BR BRPI0808801-2A patent/BRPI0808801A2/pt not_active IP Right Cessation
- 2008-03-14 AR ARP080101092A patent/AR065778A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008503475A5 (OSRAM) | ||
| HRP20180965T1 (hr) | Formulacija lijeka s produženim otpuštanjem | |
| JP5426018B2 (ja) | 易服用性固形製剤 | |
| JP2005320354A5 (OSRAM) | ||
| JP2010521437A5 (OSRAM) | ||
| JP2009545560A5 (OSRAM) | ||
| JP5592902B2 (ja) | 治療薬の徐放性組成物 | |
| JP2016006108A5 (OSRAM) | ||
| ES2294979T1 (es) | Formulacion de levetiracetam de liberacion prolongada. | |
| JP2016199602A5 (OSRAM) | ||
| JP2007528901A5 (OSRAM) | ||
| JP2013545762A5 (OSRAM) | ||
| JP2009541419A5 (OSRAM) | ||
| HRP20240564T1 (hr) | Novi farmaceutski sastav | |
| CN104114163A (zh) | 治疗心血管疾病的方法 | |
| WO2013046453A1 (ja) | 易服用性固形製剤 | |
| HRP20190069T1 (hr) | Farmaceutske formulacije koje sadrže ccr3 antagoniste | |
| RU2009138048A (ru) | Дозированные формы с задержанным на определенное время пульсирующим высвобождением | |
| WO2014027334A2 (es) | Composicion farmacéutica oral en forma de microesferas y proceso de elaboración | |
| EP3220898A1 (en) | Pharmaceutical bead formulations comprising dimethyl fumarate | |
| CN102369022A (zh) | 硬胶囊 | |
| JP2008536931A5 (OSRAM) | ||
| ES2663357T3 (es) | Formulaciones de mazindol | |
| AU2014237934B2 (en) | Controlled release pharmaceutical dosage forms | |
| WO2016050160A1 (zh) | 一种帕利哌酮口服控释片及其制备方法 |